Product Program year 2024 Source: CMS Open Payments

Vigpoder

Drug Pediatric Neurology

NDC 80789-117-50

Open in the dashboard

General payments

$11,372

278 payments

Research payments

$0

0 payments

Through program year 2024, $11,372 in general payments and $0 in research payments were reported against Vigpoder (Pediatric Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $9,690 260
2023 General $1,682 18

Breakdown

Who paid General payments · program years 2023–2024
  1. Pyros Pharmaceuticals, Inc. $11,372 278 payments
Top recipients General payments · program year 2024
  1. Osman Farooq Neurology · Buffalo, NY $482 5% · 2 payments
  2. Jennifer McVige Neurology · Amherst, NY $233 2% · 2 payments
  3. Beck Espiritu Nurse Practitioner · Ventura, CA $208 2% · 3 payments
  4. Aran Groves Neurodevelopmental Disabilities · Portland, OR $208 2% · 3 payments
  5. Khalid Kakish Neurology with Special Qualifications in Child Neurology · Buffalo, NY $207 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $3,911 42% · 72 practitioners
  2. Neurology Psychiatry & Neurology $1,977 21% · 28 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $487 5% · 12 practitioners
  4. Neurodevelopmental Disabilities Pediatrics $403 4% · 4 practitioners
  5. Epilepsy Psychiatry & Neurology $386 4% · 4 practitioners

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $1,726 18% · 16 recipients
  2. New York $1,657 17% · 12 recipients
  3. Michigan $1,252 13% · 36 recipients
  4. Texas $852 9% · 20 recipients
  5. Tennessee $546 6% · 9 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

278 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record